COPD and the risk of poor outcomes in COVID-19: A systematic review and meta-analysis.

ABSTRACT:

Background

Patients with chronic obstructive pulmonary disease (COPD) are highly susceptible from respiratory exacerbations from viral respiratory tract infections. However, it is unclear whether they are at increased risk of COVID-19 pneumonia or COVID-19-related mortality. We aimed to determine whether COPD is a risk factor for adverse COVID-19 outcomes including hospitalization, severe COVID-19, or death.

Methods

Following the PRISMA guidelines, we performed a systematic review of COVID-19 clinical studies published between November 1^st, 2019 and January 28^th, 2021 (PROSPERO ID: CRD42020191491). We included studies that quantified the number of COPD patients, and reported at least one of the following outcomes stratified by COPD status: hospitalizati

SUBMITTER: Gerayeli FV 

PROVIDER: S-EPMC7971471 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature